EP Patent

EP4238417A3 — Apparatus and method for ex vivo lung ventilation with a varying exterior pressure

Assigned to Transmedics Inc · Expires 2023-12-06 · 2y expired

What this patent protects

The present disclosure relates to a method of ventilating excised lungs. A ventilation gas is supplied to an airway of a lung and a vacuum is formed around the lung. A quality of the vacuum is varied between a lower level and a higher level to cause the lung to breathe, while the…

USPTO Abstract

The present disclosure relates to a method of ventilating excised lungs. A ventilation gas is supplied to an airway of a lung and a vacuum is formed around the lung. A quality of the vacuum is varied between a lower level and a higher level to cause the lung to breathe, while the pressure of the ventilation gas supplied to the airway is regulated to maintain a positive airway pressure in the airway of the lung. The vacuum may be cyclically varied between the two vacuum levels. The levels may be maintained substantially constant over a period of time, or one or both of the lower and higher levels may be adjusted during ventilation. The lung may be placed in a sealed chamber, and a vacuum is formed in the chamber around the lung.

Drugs covered by this patent

Patent Metadata

Patent number
EP4238417A3
Jurisdiction
EP
Classification
Expires
2023-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Transmedics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.